Abstract
Oral anticoagulants are efficient drugs on prevention of thromboembolic events in several clinical conditions. The therapy with oral anticoagulants is evaluated by the international normalized ratio (INR) of the protrombine time. Increased INR values are associated with the risk for potentially lethal bleeding and reduced INR are related to thromboembolism risk. In this regard, proceeding…